ArticleImmunity2022

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8

Karl L Banta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.